X

Health Care

Biogen’s (BIIB) long-term prospects look intact despite Alzheimer’s drug setback

Biogen Inc. (NASDAQ: BIIB) is currently going through a difficult phase as the biotechnology firm’s main products face stiff competition…

PetIQ Inc. (PETQ) Q1 2022 Earnings Call Transcript

PetIQ Inc.  (NASDAQ: PETQ) Q1 2022 earnings call dated May. 04, 2022 Corporate Participants: Katie Turner -- Investor Relations McCord Christensen -- Chief Executive…

Jazz Pharmaceuticals PLC (JAZZ) Q1 2022 Earnings Call Transcript

Jazz Pharmaceuticals PLC  (NASDAQ: JAZZ) Q1 2022 earnings call dated May. 04, 2022 Corporate Participants: Andrea N. Flynn -- Vice President, Head,…

10X Genomics Inc. (TXG) Q1 2022 Earnings Call Transcript

10X Genomics Inc.  (NASDAQ: TXG) Q1 2022 earnings call dated May. 04, 2022 Corporate Participants: Cassie Corneau -- Manager, Investor Relations &…

CVS Health Corporation (CVS) Q1 2022 Earnings Call Transcript

CVS Health Corporation  (NYSE: CVS) Q1 2022 earnings call dated May. 04, 2022 Corporate Participants: Tom Cowhey -- Senior Vice President, Capital…

Regeneron Pharmaceuticals Inc. (REGN) Q1 2022 Earnings Call Transcript

Regeneron Pharmaceuticals Inc.  (NASDAQ: REGN) Q1 2022 earnings call dated May. 04, 2022 Corporate Participants: Ryan Crowe -- Vice President of Investor…

Moderna Inc. (MRNA) Q1 2022 Earnings Call Transcript

Moderna Inc.  (NASDAQ: MRNA) Q1 2022 earnings call dated May. 04, 2022 Corporate Participants: Lavina Talukdar -- Senior Vice President and Head…

CVS Health Earnings Q1 2022: Here are the key highlights from the results

CVS Health (NYSE: CVS) reported first quarter 2022 earnings results today. Total revenues for the quarter increased to $76.8 billion,…

Pfizer Inc. (PFE) Q1 2022 Earnings Call Transcript

Pfizer Inc.  (NYSE: PFE) Q1 2022 earnings call dated May. 03, 2022 Corporate Participants: Chris Stevo -- Senior Vice President and Chief…

Sage Therapeutics Inc. (SAGE) Q1 2022 Earnings Call Transcript

Sage Therapeutics Inc.  (NASDAQ: SAGE) Q1 2022 earnings call dated May. 03, 2022 Corporate Participants: Helen Rubinstein -- Investor Relations Barry Greene -- Chief…

Stock Watch: Should you invest in Eli Lilly (LLY) after Q1 earnings?

For Eli Lilly and Company (NYSE: LLY), 2021 was a fruitful year in terms of financial performance and product development.…

Pfizer (PFE) anticipates an increase in orders for Paxlovid in coming months due to virus mutations

Shares of Pfizer Inc. (NYSE: PFE) gained nearly 2% on Tuesday after the company delivered better-than-expected results for the first…

Trxade Health Inc. (NASDAQ: MEDS) Q1 2022 Research Summary

Trxade Health Inc. (NASDAQ: MEDS) is a health service IT company focused on optimizing drug procurement and patient engagement. It…

Key highlights from Biogen’s (BIIB) Q1 2022 earnings results

Biogen Inc. (NASDAQ: BIIB) reported first quarter 2022 earnings results today. Total revenue decreased 6% year-over-year to $2.53 billion. GAAP net…

PFE Earnings: All you need to know about Pfizer’s Q1 2022 earnings results

Pfizer Inc. (NYSE: PFE) reported first quarter 2022 earnings results today. Total revenues increased 77% year-over-year to $25.7 billion. Reported…

Earnings: Highlights of Eli Lilly’s (LLY) Q1 2022 results

Eli Lilly and Company (NYSE: LLY) has reported higher earnings and revenues for the first quarter of 2022. The numbers…

AbbVie (ABBV) Q1 2022 Earnings Call Transcript

AbbVie  (NYSE: ABBV) Q1 2022 earnings call dated Apr. 29, 2022 Corporate Participants: Elizabeth Shea -- Vice President, Head of Investor Relations…

AstraZeneca PLC (AZN) Q1 2022 Earnings Call Transcript

AstraZeneca PLC  (NYSE: AZN) Q1 2022 earnings call dated Apr. 29, 2022 Corporate Participants: Chris Sheldon -- Head of Investor Relations Pascal…

Eli Lilly and Company (LLY) Q1 2022 Earnings Call Transcript

Eli Lilly and Company  (NYSE: LLY) Q1 2022 earnings call dated Apr. 28, 2022 Corporate Participants: Kevin Hern -- Vice President of…

Merck & Co. Inc. (MRK) Q1 2022 Earnings Call Transcript

Merck & Co. Inc.  (NYSE: MRK) Q1 2022 earnings call dated Apr. 28, 2022 Corporate Participants: Peter Dannenbaum -- Vice President of…

BioMarin Pharmaceutical Inc. (BMRN) Q1 2022 Earnings Call Transcript

BioMarin Pharmaceutical Inc.  (NASDAQ: BMRN) Q1 2022 earnings call dated Apr. 27, 2022 Corporate Participants: Traci McCarty -- Vice President, Investor Relations…